References
Reviewed by executive management. September 16, 2026. Scientific review pending.
U.S. Food and Drug Administration, “FDA Regulation of Cannabis and Cannabis-Derived Products, Including Cannabidiol.”Source: FDA Regulation of Cannabis and Cannabis-Derived Products, Including Cannabidiol (CBD). Last checked: .
CMS, “Substance Access Beneficiary Engagement Incentive”Source: CMS: Substance Access Beneficiary Engagement Incentive. Last checked: .
Public Law 119-37 §781Source: Public Law 119-37, Section 781. Last checked: .